Methods and composition for inducing satiety

US9295712B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9295712-B2
Application numberUS-201214350826-A
CountryUS
Kind codeB2
Filing dateOct 11, 2012
Priority dateOct 19, 2011
Publication dateMar 29, 2016
Grant dateMar 29, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A flowable or spoonable medicament, food, food ingredient or food supplement is useful for inducing satiety. It comprises a protein and a methylcellulose (MC), wherein the weight ratio w(protein)/w(MC) is at least 0.7/1.0 and the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups.

First claim

Opening claim text (preview).

The invention claimed is: 1. A flowable or spoonable medicament, food, food ingredient or food supplement comprising a protein and a methylcellulose, wherein the weight ratio w(protein)/w(methylcellulose) is at least 0.7/1.0 and the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.36 or less, wherein s23 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 3-positions of the anhydroglucose unit are substituted with methyl groups and wherein s26 is the molar fraction of anhydroglucose units wherein only the two hydroxy groups in the 2- and 6-positions of the anhydroglucose unit are substituted with methyl groups. 2. The medicament, food, food ingredient or food supplement of claim 1 , wherein the methylcellulose has a DS(methyl) of from 1.55 to 2.25. 3. The medicament, food, food ingredient or food supplement of claim 1 , wherein the weight ratio w(protein)/w(methylcellulose) is from 2.0/1.0 to 40/1.0. 4. The medicament, food, food ingredient or food supplement of claim 1 , wherein the medicament, food, food ingredient or food supplement is useful for indications that require gastric volume to be occupied for at least 60 minutes. 5. The medicament, food, food ingredient or food supplement of claim 1 , that when ingested by an individual, forms a gel mass in the individual's stomach. 6. The medicament, food, food ingredient or food supplement of claim 1 , wherein the medicament, food, food ingredient or food supplement additionally comprises an aqueous liquid and the amount of the methylcellulose is 1.0 to 2.5 weight percent, based on the total weight of the liquid composition. 7. The medicament, food, food ingredient or food supplement of claim 1 being in powder or granular form designed to be mixed with an aqueous liquid before consumption. 8. The food, food ingredient or food supplement of claim 1 , wherein the food, food ingredient or food supplement is useful as a slimming aid, weight loss aid, or weight control aid in a non-obese individual. 9. The medicament of claim 1 , wherein the medicament is useful for treating gastric ulcers, gastro-esophageal reflux disease, or obesity. 10. A method for inducing satiety or for reversibly reducing stomach void volume in an individual, comprising administering to said individual the medicament, food, food ingredient or food supplement of claim 1 . 11. A method of reducing caloric intake in an individual, comprising administering to said individual the medicament, food, food ingredient or food supplement of claim 1 . 12. The method of claim 10 , wherein the medicament, food, food ingredient or food supplement is administered at least 45 minutes before the individual eats. 13. The method of claim 10 , wherein the individual is obese. 14. The method of claim 10 , wherein the individual is not obese. 15. The medicament, food, food ingredient or food supplement of claim 1 , wherein the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is 0.24 or less. 16. The method of claim 11 , wherein the medicament, food, food ingredient or food supplement is administered at least 45 minutes before the individual eats. 17. The method of claim 11 , wherein the individual is obese. 18. The method of claim 11 , wherein the individual is not obese. 19. The medicament, food, food ingredient or food supplement of claim 1 wherein the protein is a soy protein in the form of an isolated protein, a protein concentrate or a protein hydrolysate and the weight ratio w(protein)/w(methylcellulose) is from 0.7/1.0 to 20/1.0. 20. The medicament, food, food ingredient or food supplement of claim 1 wherein the protein is a dairy protein in the form of an isolated protein, a protein concentrate or a protein hydrolysate and the weight ratio w(protein)/w(methylcellulose) is from 2.25/1.0 to 40/1.0.

Assignees

Inventors

Classifications

  • Nutrients, e.g. vitamins, minerals · CPC title

  • Anorexiants; Antiobesity agents · CPC title

  • for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title

  • A61K31/717Primary

    Celluloses · CPC title

  • Dairy proteins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9295712B2 cover?
A flowable or spoonable medicament, food, food ingredient or food supplement is useful for inducing satiety. It comprises a protein and a methylcellulose (MC), wherein the weight ratio w(protein)/w(MC) is at least 0.7/1.0 and the methylcellulose has anhydroglucose units joined by 1-4 linkages wherein hydroxy groups of anhydroglucose units are substituted with methyl groups such that s23/s26 is …
Who is the assignee on this patent?
Dow Global Technologies Llc
What technology area does this patent fall under?
Primary CPC classification A61K31/717. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).